The Body Aligned Podcast
The Body Aligned Podcast is your go-to space for faith-based, no-fluff wellness coaching that helps you ditch the all-or-nothing cycle and walk in lasting peace with food, movement, and your mindset.
Hosted by registered dietitian and Christian health coach Erin Coates, this show speaks to the woman who’s ready to anchor her health journey in truth, grace, and simple strategies that actually work.
Each episode is packed with powerful mindset shifts, science-backed strategies, and biblical encouragement to help you:
- Rewire self-sabotaging thoughts
- Build sustainable rhythms with food + movement
- Feel strong in your body again (without extremes)
- Invite God into your health — and trust Him with it
If you’ve ever thought, “I know what to do, I just can’t seem to stick with it,” this podcast was made for you.
You’re not starting over — you’re just getting started.
The Body Aligned Podcast
GLP-1s (Ozempic, Wegovy, Mounjaro): Science Meets Faith • What You Need to Know
In this episode of Body Aligned, Erin—your faith-fueled health coach and registered dietitian—unpacks the truth behind GLP-1 medications like Ozempic, Wegovy, and Mounjaro in a grounded, science-based, and grace-filled way.
We explore:
- What is GLP-1? How these meds mimic a natural hormone to reduce appetite and support blood sugar.
- What does the research show? Learn from large clinical trials showing 12–20% weight loss — and how benefits often reverse when the medication stops. (STEP series; REDEFINE trials)
- Cardiovascular benefits beyond weight loss. The landmark SELECT trial found that semaglutide reduced heart attack, stroke, or death by 20% in adults with obesity and heart disease—even without diabetes. The benefits persisted over four years.
(ACC Summary, among others) - Rising prescribing trends. GLP-1 medications are increasingly prescribed—even in people without diabetes—raising important questions about accessibility and stewardship.
(AJMC prescribing trends report) - Real-world weight regain. Meta-analysis data show that most people regain weight within a year of stopping GLP-1s unless underlying habits are addressed.
(The Guardian summary of weight regain findings) - Side effects & risks. From GI upset to rare but serious signals around pancreatitis or thyroid tumors—not to be ignored.
(Wikipedia GLP-1 adverse effects) - Your wise choice: Erin offers faith-based perspective and practical wisdom to help you discern if medication is a needed tool or a shortcut you're not ready for—without shame or fear.
Whether you're curious, considering, or questioning, this episode walks you through biology, budget, benefits, and belief—so you can make a decision grounded in truth and grace.
Key Studies & Sources
- SELECT trial (MACE reduction in obesity):
American College of Cardiology summary American College of Cardiology
The Lancet analysis The Lancet
New England Journal of Medicine full data New England Journal of Medicine
Four-year follow-up news Verywell Health - Prescribing Patterns:
Trends in GLP-1 prescribing (AjMC, 2025) AJMC - Weight Regain Data:
Meta-analysis of regain within one year The Guardian - Potential Anti-inflammatory Benefits (beyond weight loss):
Time Magazine overview of anti-inflammatory effects TIME - GLP-1 Adverse Effects Overview:
Wikipedia summary of side effects, including GI issues and rare thyroid risk Wikipedia - Emerging GLP-1 Therapies (REDEFINE trials):
Semaglutide + cagrilintide results (2025, NEJM) Wikipedia